跳至主要内容
临床试验/ACTRN12622000134729
ACTRN12622000134729尚未招募未知

Investigating feasibility and efficacy of a virtual UNSW Lifestyle Clinic exercise physiologist intervention for people with hypertension: a pilot randomised controlled trial

A/Prof Xiaoqi Feng0 个研究点目标入组 60 人开始时间: 2022年1月27日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • be 18 years of age or older;
  • diagnosed with hypertension and recent clinic systolic blood pressure greater than or equal to 130 mmHg and/or diastolic blood pressure greater than or equal to 80 mmHg;
  • willing to wear wrist-based blood pressure device for seven consecutive days at baseline and after 3 months;
  • willing to undergo initial exercise tests by an Exercise Physiologist to determine eligibility;
  • have access to a smartphone and the internet and feel comfortable to use it to download an App for use with a blood-pressure device, complete online assessments, and join online video consultations with an Accredited Exercise Physiologist;
  • no plan to change medications;
  • have a personal weighing bathroom scale; and
  • independently ambulant for 200m (be confident to walk 200m or around the block unassisted).

排除标准

  • significant alcohol or drug use;
  • pregnancy (or planned pregnancy);
  • unstable cardiovascular, respiratory and neurological disorders; established chronic kidney disease (eGFR <60ml/kg/1.73m2); known arrhythmias (irregular heart rhythms); known vascular aneurysm; implanted electrical devices (e.g. cardiac pacemakers or defibrillators); severe or untreated mental health illnesses (including eating disorders); active cancer or requiring treatment for cancer; other health conditions, (e.g. orthopaedic or neuromuscular limitations) or hospital admissions within the last 6 months that would make it difficult or unsafe to participate in the exercise sessions at home safely. prior mastectomy (breast removal);
  • wrist circumference >22cm and upper arm circumference >64 cm because of the BP device size;
  • participation in any other behaviour change program or clinical trial that may interfere with the outcomes of this study, e.g. weight loss, physical activity or drug;
  • unable to speak English (a translator is not available) or give written informed consent;
  • allergy to the silicone material from the BP device.

研究者

发起方
A/Prof Xiaoqi Feng

相似试验